Come up with a name for your new list and we'll add to it:
Madeleine Pharmaceuticals raised a round of funding on February 01, 2011. Investors include
Terra Rossa Capital.
Madeleine Pharmaceuticals was spun-out from Hospira's Adelaide operations. Madeleine will commercialise and manufacture a novel treatment for congestive heart failure based on a naturally occurring pe…